A Prospective Study on Sunitinib as First Line Therapy for Advanced/Metastatic Renal Cell Carcinoma in Asian Population

Clinical trial NCT02626754 · TERMINATED

Trial details

NCT number: NCT02626754
Sponsor: vghtpe user
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Renal Cell Carcinoma

Start date: 2015-08-12
Primary completion: 2018-01-02
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.